| scholarly article | Q13442814 |
| P50 | author | Cheryl A Jones | Q104021508 |
| David M Koelle | Q40734874 | ||
| P2093 | author name string | Anthony L Cunningham | |
| Lidija Bosnjak | |||
| Monica Miranda-Saksena | |||
| Ross A Boadle | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 2220-2227 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells | |
| P478 | volume | 174 |
| Q40067153 | A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4+ and CD8+ T Cells |
| Q27335068 | A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy |
| Q34178357 | A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesis |
| Q41155777 | A subset of human plasmacytoid dendritic cells expresses CD8α upon exposure to herpes simplex virus type 1. |
| Q35665813 | Activation of NF-κB in CD8+ dendritic cells Ex Vivo by the γ134.5 null mutant correlates with immunity against herpes simplex virus 1. |
| Q37602176 | An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo. |
| Q35056662 | Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection. |
| Q38067945 | Antigen presentation by Langerhans cells |
| Q34871428 | Antiviral-activated dendritic cells: a paracrine-induced response state |
| Q35792771 | Apoptosis and antigen receptor function in T and B cells following exposure to herpes simplex virus |
| Q36315467 | B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient mice |
| Q57158513 | Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL |
| Q35382523 | CD11c controls herpes simplex virus 1 responses to limit virus replication during primary infection |
| Q37185824 | Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity |
| Q26999223 | Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells |
| Q35798899 | Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion |
| Q26829669 | Changing views of the role of Langerhans cells |
| Q36878921 | Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells |
| Q35699002 | Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine |
| Q36752241 | Current concepts of HIV transmission |
| Q44033317 | Current concepts of HIV transmission |
| Q41160055 | Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis |
| Q37062606 | Design opportunities for actively targeted nanoparticle vaccines |
| Q37366646 | Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour. |
| Q36570266 | Disruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes |
| Q39254798 | Early passage neonatal and adult keratinocytes are sensitive to apoptosis induced by infection with an ICP27-null mutant of herpes simplex virus 1. |
| Q91855383 | Efferocytosis in health and disease |
| Q36171970 | Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model. |
| Q45858837 | Efficient transduction of monocyte- and CD34+-derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation. |
| Q34952284 | Entry of herpes simplex virus 1 and other alphaherpesviruses via the paired immunoglobulin-like type 2 receptor alpha |
| Q35414669 | Evasion of early antiviral responses by herpes simplex viruses |
| Q26777948 | Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses |
| Q33303686 | HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts |
| Q40554997 | HSV-1-induced activation of NF-κB protects U937 monocytic cells against both virus replication and apoptosis. |
| Q33954386 | HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target |
| Q39385114 | HSV-2 specifically down regulates HLA-C expression to render HSV-2-infected DCs susceptible to NK cell killing |
| Q37600960 | Harnessing human dendritic cell subsets to design novel vaccines |
| Q36559887 | Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy |
| Q37226117 | Herpes simplex virus and HIV-1: deciphering viral synergy |
| Q44757727 | Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling |
| Q33558390 | Herpes simplex virus type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences |
| Q41357293 | Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells |
| Q33983315 | Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture |
| Q55380684 | Ilixadencel - an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration. |
| Q33835386 | Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn |
| Q34716855 | Immunogenicity of cytopathic and noncytopathic viral vectors |
| Q37135532 | Immunological control of herpes simplex virus infections |
| Q35847995 | Immunomodulatory effects of HSV-2 infection on immature macaque dendritic cells modify innate and adaptive responses |
| Q36751598 | Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivector |
| Q33755074 | Inhibition of dendritic cell maturation by group A Streptococcus |
| Q37268972 | Insights into Langerhans cell function from Langerhans cell ablation models |
| Q37700833 | Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. |
| Q37268978 | Langerhans cells and viral immunity |
| Q37721150 | Langerhans cells: critical regulators of skin immunity? |
| Q36969195 | Lentivirus as a potent and mechanistically distinct vector for genetic immunization |
| Q37120677 | Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice |
| Q21710678 | Manipulation of dendritic cell function by viruses |
| Q64056522 | Mechanisms of Immune Control of Mucosal HSV Infection: A Guide to Rational Vaccine Design |
| Q37600490 | Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy |
| Q42951271 | Natural killer cells support the induction of protective immunity during dendritic cell-mediated vaccination against Leishmania major. |
| Q34887778 | Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells |
| Q36506900 | Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation. |
| Q35648476 | Phylogenetically Distant Viruses Use the Same BH3-Only Protein Puma to Trigger Bax/Bak-Dependent Apoptosis of Infected Mouse and Human Cells. |
| Q37694574 | Rapid host immune response and viral dynamics in herpes simplex virus-2 infection |
| Q26859623 | Recent advances in vaccine development for herpes simplex virus types I and II |
| Q35602225 | Relay of herpes simplex virus between Langerhans cells and dermal dendritic cells in human skin. |
| Q37704952 | Revisiting the tolerogenicity of epidermal Langerhans cells |
| Q42153737 | Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. |
| Q28584938 | Role of Bcl-2 expression for productive herpes simplex virus 2 replication |
| Q39103869 | Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection |
| Q39528138 | Singapore grouper iridovirus, a large DNA virus, induces nonapoptotic cell death by a cell type dependent fashion and evokes ERK signaling |
| Q34801021 | Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization |
| Q90245070 | T cell response kinetics determines neuroinfection outcomes during murine HSV infection |
| Q37107189 | T-cell immunity to human alphaherpesviruses |
| Q39938751 | TNF-alpha mediates pseudorabies virus-induced apoptosis via the activation of p38 MAPK and JNK/SAPK signaling |
| Q35692343 | The Role of Plasmacytoid Dendritic Cells in Innate and Adaptive Immune Responses against Alpha Herpes Virus Infections |
| Q36770431 | The cross-priming pathway: a portrait of an intricate immune system |
| Q36627481 | The evolving function of Langerhans cells in adaptive skin immunity |
| Q37192154 | The gamma 1 34.5 protein of herpes simplex virus 1 is required to interfere with dendritic cell maturation during productive infection |
| Q38623232 | The influence of infectious factors on dendritic cell apoptosis |
| Q37596320 | The role of dendritic cells in alphaherpesvirus infections: archetypes and paradigms |
| Q26827217 | The role of dendritic cells in immunity against primary herpes simplex virus infections |
| Q37952807 | The tug-of-war between dendritic cells and human chronic viruses |
| Q38802627 | Transcription Factor NF-κB: An Update on Intervention Strategies |
| Q45324219 | US6 Gene Deletion in Herpes Simplex Virus Type 2 Enhances Dendritic Cell Function and T Cell Activation. |
| Q26741484 | Understanding natural herpes simplex virus immunity to inform next-generation vaccine design |
| Q80809469 | Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice |
| Q35077019 | Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon |
| Q37743180 | Viruses and Langerhans cells |
| Q47139789 | What Goes Around, Comes Around - HSV-1 Replication in Monocyte-Derived Dendritic Cells |
Search more.